标题
Real-time cell cycle imaging during melanoma growth, invasion, and drug response
作者
关键词
-
出版物
Pigment Cell & Melanoma Research
Volume 27, Issue 5, Pages 764-776
出版商
Wiley
发表日期
2014-06-05
DOI
10.1111/pcmr.12274
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Melanoma never says die
- (2014) Nikolas K. Haass et al. EXPERIMENTAL DERMATOLOGY
- A quantitative approach to histopathological dissection of elastin-related disorders using multiphoton microscopy
- (2013) P.L. Tong et al. BRITISH JOURNAL OF DERMATOLOGY
- Hypoxia Contributes to Melanoma Heterogeneity by Triggering HIF1α-Dependent Phenotype Switching
- (2013) Daniel S. Widmer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines
- (2013) A Vultur et al. ONCOGENE
- Melanoma’s connections to the tumour microenvironment
- (2013) Johanna M. Brandner et al. PATHOLOGY
- DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma
- (2013) Sandra Pavey et al. Pigment Cell & Melanoma Research
- Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2
- (2013) M. P. O'Connell et al. Cancer Discovery
- An oxygen-permeable spheroid culture system for the prevention of central hypoxia and necrosis of spheroids
- (2012) Takahisa Anada et al. BIOMATERIALS
- Melanoma: from mutations to medicine
- (2012) H. Tsao et al. GENES & DEVELOPMENT
- Intravital multiphoton imaging of immune responses in the mouse ear skin
- (2012) Jackson LiangYao Li et al. Nature Protocols
- Mechanisms of intrinsic and acquired resistance to kinase-targeted therapies
- (2012) Shubha Bagrodia et al. Pigment Cell & Melanoma Research
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737
- (2011) K. M. Lucas et al. CLINICAL CANCER RESEARCH
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer invasion and resistance: interconnected processes of disease progression and therapy failure
- (2011) Stephanie Alexander et al. TRENDS IN MOLECULAR MEDICINE
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Moving Targets That Drive Cancer Progression
- (2010) Mark Shackleton NEW ENGLAND JOURNAL OF MEDICINE
- Cancer stem cells versus phenotype-switching in melanoma
- (2010) Keith S. Hoek et al. Pigment Cell & Melanoma Research
- PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas
- (2010) John T. Lee et al. Pigment Cell & Melanoma Research
- A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status
- (2010) Marie C. Zipser et al. Pigment Cell & Melanoma Research
- Melanocytes: From Morphology to Application
- (2009) A. Santiago-Walker et al. SKIN PHARMACOLOGY AND PHYSIOLOGY
- In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
- (2008) K. S. Hoek et al. CANCER RESEARCH
- Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression
- (2008) Asako Sakaue-Sawano et al. CELL
- The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel
- (2008) N. K. Haass et al. CLINICAL CANCER RESEARCH
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- (2008) J. Tsai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Melanoma and the tumor microenvironment
- (2008) Jessie Villanueva et al. Current Oncology Reports
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started